Fogarty Clinical Research
Mountain View, California, 94040, United States
NCT Number: NCT01811446
The purpose of this study is to determine whether muscle activation can be accomplished more effectively and comfortably in challenging subjects using novel configurations of an activation device. A novel device will be compared side by side with a market leading device.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Mountain View, California, 94040, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will receive muscle activation technology from the Niveus device on one leg and from the Intelect (commercially-available third-party) device on the other. The order of use and the leg applied to will be randomized.
Time frame: During treatment
Intensity required to achieve target levels of muscle contraction
Time frame: During treatment
Comfort of stimulation will be assessed at various intensity levels using a widely-used discomfort scale
Niveus Medical, Inc.
Industry
Evaluation of Muscle Stimulation Efficiency in Challenging Subjects: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06474858
Body Weight, COPD
Arnhem, Netherlands
View Trial DetailsNCT02634268
Behavior, Body Weight
Birmingham, Alabama, United States
View Trial DetailsNCT02157844
Apnea, Body Weight
College Station, Texas, United States
View Trial DetailsNCT04515758
Body Weight, Bone Diseases
Kitchener, Ontario, Canada
View Trial Details